Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes

Phase 4

Completed

• Conditions: Type 2 Diabetes Mellitus
• Interventions: Drug: rosiglitazone; Drug: metformin; Drug: Anti-diabetic medications

• Registration Number: NCT00373178
• Lead Sponsor: Aristotle University Of Thessaloniki

Brief Summary

The aim of the present study is to investigate the influence of several anti-diabetic regimens (metformin,glitazone,sulfonylurea,glinidine) and diet on metabolic parameters in patients with recently diagnosed type 2 diabetes.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-01
• Study First Submitted: 2006-09-06
• Study First Submitted QC: 2006-09-06
• Study First Posted: 2006-09-07
• Primary Completion: 2007-01
• Study Completion: 2008-06
• Status Verified: 2012-11
• Last Update Submitted: 2012-11-01
• Last Update Posted: 2012-11-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Recently diagnosed type 2 diabetes
• No previous anti-diabetic medications

Exclusion Criteria

• Heart failure
• Renal disease
• Liver disease
• Life-threatening diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Metformin,lifestyle counselling	Anti-diabetic medications	-
Metformin,lifestyle counselling	rosiglitazone	-
Metformin,lifestyle counselling	metformin	-

Primary Outcome Measures

Name	Time	Method
Novel cardiovascular risk factors modification	2 years

Secondary Outcome Measures

Name	Time	Method
Lipid and glucose regulation	2 years

Trial Locations

Locations (2)

AHEPA University Hospital of Thessaloniki; 🇬🇷 Thessaloniki, Greece

Aristotle University of Thessaloniki; 🇬🇷 Thessaloniki, Greece